← Back to Patent Explorer
US4889799A Expired / Lapsed US ⏱️ 0.0 years remaining

Reagent kit producing shortened target DNA segments usable in sequencing large DNA segments

Assignee: Fred Hutchinson Cancer Center
•
Filing: 1987-04-10
•
Granted: 1989-12-26
•
Expires: 2007-04-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process is provided for producing an ordered series of cloned, circular, DNA molecules containing shortened target DNA segments derived from a long target DNA segment, which are suitable for use in determining the nucleotide sequence of the long target DNA segment, or for targeting specific regions within the target DNA segment. The process includes producing, by molecular cloning, a plurality of double-stranded recombinant DNA molecules each containing: (i) vector DNA; (ii) a sequencing primer binding site; and, (iii) a DNA region having unique endonuclease sites and a long target DNA segment. The sequencing primer binding site is spaced from the long target DNA segment by at least a portion of said DNA region having the unique endonuclease sites. The plurality of double-stranded circular recombinant DNA molecules are cleared using two restriction endonucleases. The cleavage occurs in the portion of the DNA having unique endonuclease sites lying between the long target DNA segment and the sequencing primer binding site. The cleavage and, if necessary, subsequent processing steps, produces double-stranded linear DNA molecules having an end containing a long target DNA segment that is susceptible to exonuclease digestion and a sequencing primer binding site end that is not susceptible to exonuclease digestion. Next, the target DNA segment end is subjected to exonuclease digestion. At timed intervals, portions of the exonuclease digested linear double-stranded DNA molecules are removed. Since part of the target DNA segment has been deleted by the exonuclease, the removed linear double-stranded DNA molecules include shortened target DNA segments. Next, the removed linear double-stranded DNA molecules are blunted and then recircularized to reform circular recombinant DNA molecules. The reformed recombinant DNA molecules are cloned to produce a plurality of circular DNA molecules containing shortened target DNA segments that differ in length by the amount of target DNA that was removed by the exonuclease. The reformed circular DNA molecules are suitable for use in DNA sequencing other molecular manipulations of genetic material.

Inventors

  • 👤 Steven Henikoff
  • 👤 Richard E. Gelinas

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 02:31
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6869; C12N; C12N15/00; C12N15/09; C12N15/10

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 188 words
A reagent kit for producing shortened DNA fragments useful for sequencing a target DNA segment, comprising in combination: (a) a purified exonuclease reagent capable of unidirectionally digesting nucleotide bases synchronously from a target DNA segment; and, (b) a purified recombinant vector molecule comprising vector DNA, a sequencing primer binding site, and a polylinker region comprising first, second, and third restriction endonuclease sites, the first restriction site being capable of receiving by ligation the target DNA segment, the second and third restriction sites being located between the first restriction site and the sequencing primer binding site, and the second and third restriction sites being so arranged that cleavage of the polylinker region at the second and third restriction sites will produce a linearized vector molecule having a first terminus adjacent the target DNA segment that is susceptible to digestion by the exonuclease reagent and a second terminus, not susceptible to digestion by the exonuclease reagent adjacent the sequencing primer binding site wherein said purified exonuclease reagent and said purified recombinant vector molecule are present in amounts sufficient to produce shortened DNA fragments useful for sequencing a target DNA segment.
Claim 2
Dependent Claim 188 words
A reagent kit for producing shortened DNA fragments useful for sequencing a target DNA segment, comprising in combination: (a) a purified exonuclease reagent capable of unidirectionally digesting nucleotide bases synchronously from a target DNA segment; and, (b) a purified recombinant vector molecule comprising vector DNA, a sequencing primer binding site, and a polylinker region comprising first, second, and third restriction endonuclease sites, the first restriction site being capable of receiving by ligation the target DNA segment, the second and third restriction sites being located between the first restriction site and the sequencing primer binding site, and the second and third restriction sites being so arranged that cleavage of the polylinker region at the second and third restriction sites will produce a linearized vector molecule having a first terminus adjacent the target DNA segment that is susceptible to digestion by the exonuclease reagent and a second terminus, not susceptible to digestion by the exonuclease reagent adjacent the sequencing primer binding site wherein said purified exonuclease reagent and said purified recombinant vector molecule are present in amounts sufficient to produce shortened DNA fragments useful for sequencing a target DNA segment.
Claim 3
Dependent Claim 13 words
A reagent kit according to claim 1, wherein the exonuclease is Exonuclease III.
Claim 4
Dependent Claim 28 words
A reagent kit according to claim 2, wherein one of the second and third restriction endonuclease sites provides a four-nucleotide 3' protrusion adjacent the sequencing primer binding site.
Claim 5
Dependent Claim 31 words
A reagent kit according to claim 1, wherein at least one of the second and third restriction endonuclease sites is selected from the group consisting of Not I and Sfi I.
Claim 6
Dependent Claim 22 words
A reagent kit according to claim 1, wherein the vector molecule is selected from the group consisting of plasmids and bacteriophage vectors.
Claim 7
Dependent Claim 18 words
A reagent kit according to claim 1, wherein the vector molecule is a derivative of a M13 bacteriophage.
Claim 8
Dependent Claim 14 words
A reagent kit according to claim 1, further comprising a single-strand specific nuclease enzyme.
Claim 9
Dependent Claim 26 words
A reagent kit according to claim 7, wherein the single-strand specific nuclease enzyme is selected from the group consisting of S1 nuclease and mung bean nuclease.
Claim 10
Dependent Claim 12 words
A reagent kit according to claim 1, further comprising a DNA polymerase.
Claim 11
Dependent Claim 18 words
A reagent kit according to claim 9, wherein the DNA polymerase is large fragment (Klenow) DNA polymerase I.
Claim 12
Dependent Claim 16 words
A reagent kit according to claim 1, further comprising a mixture of the four deoxynucleotide triphosphates.
Claim 13
Dependent Claim 12 words
A reagent kit according to claim 1, further comprising a DNA ligase.
Claim 14
Dependent Claim 16 words
A reagent kit according to claim 12, wherein the DNA ligase is T 4 DNA ligase.
Claim 15
Dependent Claim 86 words
A reagent kit according to claim 1, further comprising a description of a process for producing shortened DNA fragments useful for sequencing a target DNA segment, the process comprising the steps of inserting a target DNA segment into the recombinant vector molecule, cloning the vector molecule containing the target DNA insert, linearizing the vector molecule so as to render one end of the linearized molecule adjacent the target DNA insert susceptible to digestion by the exonuclease, and thereafter digesting the linearized vector molecule with the exonuclease.
Claim 16
Dependent Claim 39 words
A reagent kit according to claim 1, further comprising one or more solutions selected from the group consisting of exonuclease digestion buffer, single-strand specific nuclease digestion buffer, single-strand specific nuclease termination buffer, DNA polymerase buffer, and DNA ligase buffer.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-12-25 1993-06-26 1993-12-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-12-25 1997-06-26 1997-12-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-12-25 2001-06-26 2001-12-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag